Parallel Imports of Pharmaceutical Products in the European Union

Parallel Imports of Pharmaceutical Products in the European Union

The point of parallel imports of pharmaceuticals is arbitrage between countries with different prices. For several years, an important issue in the European Union (EU) has been the evident conflict between differing price regulations in the member...

Full description

Bibliographic Details
Main Authors: Ganslandt, Mattias, Maskus, Keith E.
Format: Policy Research Working Paper
Language:English
en_US
Published: World Bank, Washington, DC 2014
Subjects:
AVERAGE PRICES
BASE YEAR
BENCHMARK
COMMON MARKET
CONSUMERS
CONVERGENCE HYPOTHESIS
COST INCREASES
DEMAND FUNCTIONS
ECONOMETRIC ANALYSIS
EMPIRICAL ANALYSIS
EQUILIBRIUM
EXCLUSIVE RIGHTS
EXPORT MARKETS
EXPORTS
GDP
HOME MARKET
HOME MARKETS
IMPORTS
INCOME
INCOME LEVELS
INDUSTRIAL ECONOMICS
MARGINAL COST
MARGINAL REVENUE
MARGINAL UTILITY
MARKET INTEGRATION
MARKETING
MONOPOLIES
PATENTS
POLICY MAKERS
PRICE CEILINGS
PRICE CHANGES
PRICE COMPARISONS
PRICE CONTROL
PRICE CONTROLS
PRICE EFFECT
PRICE REGULATION
PROPERTY RIGHTS
SALES
SUBSTITUTION
TOTAL SALES
TRADEMARKS
UTILITY FUNCTION
WELFARE EFFECTS
WHOLESALE PRICES
WHOLESALERS
Online Access:http://documents.worldbank.org/curated/en/2001/07/1551961/parallel-imports-pharmaceutical-products-european-union
http://hdl.handle.net/10986/19584

Internet

http://documents.worldbank.org/curated/en/2001/07/1551961/parallel-imports-pharmaceutical-products-european-union
http://hdl.handle.net/10986/19584

Similar Items